In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: The search for an accurate, gene-based test to identify heritable risk factors for Reward Deficiency Syndrome (RDS) was conducted based on hundreds of published studies about the role of dopamine in addictive behaviors, including risk for drug dependence and compulsive/impulsive behavior disorders. The term RDS was first coined by Blum’s group in 1995 to identify a group of behaviors with a common neurobiological mechanism associated with a polymorphic allelic propensity for hypodopaminergia. Objectives: To outline the process used to select risk alleles of reward genes for the Genetic Addiction Risk Score (GARS) test. Consequently, to address the limitations caused by inconsistent results that occur in many case-control behavioral association studies. These limitations are perhaps due to the failure of investigators to adequately screen controls for drug and alcohol use disorder, and any of the many RDS behaviors, including nicotine dependence, obesity, pathological gambling, and internet gaming addiction. Method: Review of the literature related to the function of risk alleles of reward genes associated with hypodopaminergia relevant case-control association studies for the selection of alleles to be measured by the Genetic Addiction Risk Score (GARS) test. Result: The prevalence of the DRD2 A1 allele in unscreened controls (33.3%), compared to “Super-Controls” [highly screened RDS controls (3.3%) in proband and family] is used to exemplify a possible solution. Conclusion: Unlike One Gene-One Disease (OGOD), RDS is polygenetic, and very complex. In addition, any RDS-related behaviors must be eliminated from the control group in order to obtain the best possible statistical analysis instead of comparing the phenotype with diseaseridden controls.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurobiology of addiction: a neurocircuitry analysis
Koob, G. F., & Volkow, N. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00104-8 · Cited by 3,698
Allelic Association of Human Dopamine D2 Receptor Gene in Alcoholism
Blum, K. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440150063027 · Cited by 1,055
Self-citationNoble, E. P. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310066012 · Cited by 655
The D 2 Dopamine Receptor Gene as a Determinant of Reward Deficiency Syndrome
Blum, K., Sheridan, P. J., Wood, R. C., Braverman, E. R., Chen, T. J. H., phd, J. G. C., & Comings, D. E. (1996) · Journal of the Royal Society of Medicine · doi:10.1177/014107689608900711 · Cited by 443
Self-citationBlum, K. (2018) · Frontiers in Bioscience · doi:10.2741/s518 · Cited by 143
Self-citationGenetic addiction risk score GARS trade a predictor of vulnerability to opioid dependence
Blum, K. (2018) · Frontiers in Bioscience · doi:10.2741/e816 · Cited by 104
Self-citationWichers, M., Aguilera, M., Kenis, G., Krabbendam, L., Myin-Germeys, I., Jacobs, N., Peeters, F., Derom, C., Vlietinck, R., Mengelers, R., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301520 · Cited by 78
Cited by
Wichers, M., Aguilera, M., Kenis, G., Krabbendam, L., Myin-Germeys, I., Jacobs, N., Peeters, F., Derom, C., Vlietinck, R., Mengelers, R., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301520 · Cited by 78
Blum, K., Steinberg, B., Gondré-Lewis, M. C., Baron, D., Modestino, E. J., Badgaiyan, R. D., Downs, B. W., Bagchi, D., Brewer, R., McLaughlin, T., et al. (2021) · Psychology Research and Behavior Management · doi:10.2147/prbm.s292958 · Cited by 20
Self-citationBlum, K., Bowirrat, A., Baron, D., Elman, I., Makale, M. T., Cadet, J. L., Thanos, P. K., Hanna, C., Ahmed, R., Gondre-Lewis, M. C., et al. (2024) · Gene & Protein in Disease · doi:10.36922/gpd.1966 · Cited by 14
“118 Moreover, as previously pointed out by several researchers, 89–104 reduced ligand binding of DRD2 has consistently been observed in the striatum of individuals with AUD and other RDS behaviors.”
BackgroundSelf-citationSummary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography
(2024) · Journal of Addiction Psychiatry · doi:10.17756/jap.2024-043 · Cited by 11
Self-citationGold, M. S., Blum, K., Bowirrat, A., Pinhasov, A., Bagchi, D., A. Dennen, C., K. Thanos, P., Hanna, C., Lewandrowski, K.-U., Sharafshah, A., et al. (2024) · INNOSC Theranostics and Pharmacological Sciences · doi:10.36922/itps.1918 · Cited by 9
Self-citation
Metadata
- Authors
- Blum, K., Baron, D., Lott, L., Ponce, J. V., Siwicki, D., Boyett, B., Steinberg, B., Modestino, E. J., Fried, L., Hauser, M., Simpatico, T., Downs, B. W., McLaughlin, T., Hajela, R., & Badgaiyan, R. D.
- Venue
- Current Psychopharmacology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2020-04-25
- Volume
- 9
- Issue
- 1
- Pages
- 7-21
- ISSN
- 2211-5560 (ISSN-L)
- OpenAlex
- W2987596803
- Cited by
- 35
- References
- 7
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing. https://app.cochat.ai/papers/10.2174/2211556008666191111103152
- The paper
- Blum, K., Baron, D., Lott, L., Ponce, J. V., Siwicki, D., Boyett, B., Steinberg, B., Modestino, E. J., Fried, L., Hauser, M., Simpatico, T., Downs, B. W., McLaughlin, T., Hajela, R., & Badgaiyan, R. D. (2020). In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing. Current Psychopharmacology. https://doi.org/10.2174/2211556008666191111103152
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.